Ternary Cu(II) complex with GHK peptide and cis-urocanic acid as a potential physiologically functional copper chelate
When starting GLP-1 RAs, these findings suggest the need for individualized medicine strategies, which may include careful patient selection, risk-benefit analyses, and possibly introducing earlier or more frequent colorectal cancer screening for high-risk patients
Taking in consideration the shorter duration and lower dose of semaglutide, the 34% greater weight loss with semaglutide as compared to liraglutide seen in the current study is in line with previous clinical studies
Published: Thursday, December 11, 2025 OKLAHOMA CITY The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type 2 diabetes
Comfort Counts : Proper technique and site selection reduce pain, bruising, and anxiety
Evaluation of oxidative stress level: Total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19